GSK Investigational Site is a clinical research site located in Tacoma, Washington, United States 98405.
Crixeo Clinical Trials Trust Score: 30/100 (FAILING). This profile has not yet been claimed by the site owner.
GSK Investigational Site has participated in 89 clinical trials with 4 currently active.
Therapeutic areas: Cancer, Lung Cancer, Non-Small Cell, Non-Small-Cell Lung Cancer.
Sponsors: GlaxoSmithKline, Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA), XenoPort, Inc..
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Washington · View every site in Tacoma
Trust Score: 30/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
GSK Investigational Site has a Crixeo Trust Score of 30/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
GSK Investigational Site has 89 clinical trials on record, with 4 currently active. Their work covers Cancer, Lung Cancer, Non-Small Cell, Non-Small-Cell Lung Cancer.
GSK Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.